Intra-tumoral bacteria in breast cancer and intervention strategies☆

被引:0
|
作者
Hou, Ting [1 ,2 ,3 ]
Huang, Xiaoling [1 ,2 ,3 ]
Lai, Jiahui [1 ,2 ,3 ]
Zhou, Dongfang [1 ,2 ,3 ,4 ]
机构
[1] Southern Med Univ, Sch Pharmaceut Sci, NMPA Key Lab Res & Evaluat Drug Metab, Guangzhou 510515, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[3] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Hongkong Macao Joint Lab New Drug Screen, Guangzhou 510515, Guangdong, Peoples R China
[4] Southern Med Univ, Minist Educ, Key Lab Mental Hlth, Guangzhou 510515, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; Intra-tumoral bacteria; Cancer treatment; Intervention strategies; FUSOBACTERIUM-NUCLEATUM; COLORECTAL-CANCER; CELL-ADHESION; MICROBIOTA; FAP2; METASTASIS; GUT; CARCINOGENESIS; INFLAMMATION; ANTIBIOTICS;
D O I
10.1016/j.addr.2025.115516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The microbiome, consisting of a wide range of both beneficial and harmful microorganisms, is vital to various physiological and pathological processes in the human body, including cancer pathogenesis. Tumor progression is often accompanied by the destruction of the vascular system, allowing bacteria to circulate into the tumor area and flourish in an immunosuppressive environment. Microbes are recognized as significant components of the tumor microenvironment. Recent research has increasingly focused on the role of intra-tumoral bacteria in the onset, progression, and treatment of breast cancer-the most prevalent cancer among women. This review elucidates the potential mechanisms by which intra-tumoral bacteria impact breast cancer and discusses different therapeutic approaches aimed at targeting these bacteria. It provides essential insights for enhancing existing treatment paradigms while paving the way for novel anticancer interventions. As our understanding of the microbiome's intricate relationship with cancer deepens, it opens avenues for groundbreaking strategies that could redefine oncology.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Cytolytic Activity Score as a Marker for Intra-Tumoral Immunogenicity in Colorectal Cancer
    Yan, L.
    Peng, X.
    Qi, Q.
    Takabe, K.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S33 - S33
  • [22] INTRA-TUMORAL VARIATION OF ESTROGEN-RECEPTOR STATUS IN ENDOMETRIAL CANCER
    CASTAGNETTA, L
    LOCASTO, M
    MERCADANTE, T
    POLITO, L
    COWAN, S
    LEAKE, RE
    BRITISH JOURNAL OF CANCER, 1983, 47 (02) : 261 - 267
  • [23] Intra-tumoral microbes and overall survival in colorectal cancer patients.
    Malalur, Pannaga G.
    Mo, Xiaokui
    Hoyd, Rebecca
    Carbone, David Paul
    Spakowicz, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations
    Moon, Hye-ran
    Ozcelikkale, Altug
    Yang, Yi
    Elzey, Bennett D.
    Konieczny, Stephen F.
    Han, Bumsoo
    LAB ON A CHIP, 2020, 20 (20) : 3720 - 3732
  • [25] Parasellar dermoid tumor with intra-tumoral hemorrhage
    H. Mamata
    M. Matsumae
    N. Yanagimachi
    S. Matsuyama
    Y. Takamiya
    R. Tsugane
    European Radiology, 1998, 8 : 1594 - 1597
  • [26] DYNAMIC INTRA-TUMORAL EVOLUTION OF HUMAN MELANOMA
    Shackleton, M. J.
    Quintana, E.
    Li, J.
    Morrison, S. J.
    WOUND REPAIR AND REGENERATION, 2012, 20 (05) : A76 - A76
  • [27] Intra-tumoral costimulator protein transfer.
    Zheng, G
    Chen, A
    Sterner, R
    Tykocinski, ML
    FASEB JOURNAL, 2000, 14 (06): : A1137 - A1137
  • [28] Parasellar dermoid tumor with intra-tumoral hemorrhage
    Mamata, H
    Matsumae, M
    Yanagimachi, N
    Matsuyama, S
    Takamiya, Y
    Tsugane, R
    EUROPEAN RADIOLOGY, 1998, 8 (09) : 1594 - 1597
  • [29] Selective targeting or reprogramming of intra-tumoral Tregs
    Keywan Mortezaee
    Medical Oncology, 41
  • [30] EUS-guided intra-tumoral therapies
    Marc, Barthet
    Monino, Laurent
    Rimbas, Mihai
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2022, 60